India
The project partners in India include healthcare organisations, public health agencies, and international researchers. The SHE-CAN study is evaluating self-collected HPV screening to prevent cervical cancer in India.
The SHE-CAN study
Project partners in India include not-for-profit health care organisations (Christian Medical College Vellore, and Tribal Heath Initiative, Sittilingi), in collaboration with the Directorate of Public Health and Preventive Medicine for the state of Tamil Nadu, and the Population Based Cancer Registry in Mizoram. Our partners include researchers from the University of Melbourne, Baker Heart and Diabetes Institute, and the International Agency for Research on Cancer.
Participant enrolment and sample collection for the Self-collected HPV Evaluation for the Prevention of Cervical Cancer (SHE-CAN) project commenced on March 21, 2025. The SHE-CAN trial protocol manuscript was published (Oommen et al), and ACPCC staff continue to be active as investigators in this research.
The SHE-CAN trial is supported by canSCREEN® with staff trained to collect data in the study sites, in the Indian provinces of Tamil Nadu and Mizoram. canSCREEN® was translated into Tamil for this study and configured to take into account the scarce address and often missing personal details of patients available in some of these remote locations.
